Lindane Lotion — Class III drug recall D-0571-2016
Terminated recall by Morton Grove Pharmaceuticals, Inc., reported 2016-01-27, distributed nationwide. Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.
| Recall number | D-0571-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Morton Grove Pharmaceuticals, Inc., Morton Grove, IL, United States |
| Recall initiated | 2015-12-15 |
| Classified | 2016-01-15 |
| Reported by FDA | 2016-01-27 |
| Terminated | 2016-09-13 |
| Distributed | Nationwide (US) |
| Quantity | 39,187 bottles |
| Reason classes | potency, specification failure |
| NDC | 60432-0833-60 |
| Lot numbers | UP1103, UQ1001 |
| Expiration dates | 2016-04, 2017-04 |
Product
Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60
Reason for recall
Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0571-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.